Turkish Translation of The Emphasis-10 Questionnaire

Pulmonary Hypertension Clinical Trial

Official title:

Evaluation of the Validity and Reliability of the Turkish Translation of The Emphasis-10 Questionnaire in Patients With Pulmonary Hypertension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03146702
• Other study ID #: TR-034
• Status: Completed
• Phase: N/A
• First received: May 8, 2017
• Last updated: February 18, 2018
• Start date: October 2016
• Est. completion date: September 2017

Study information

• Verified date: May 2017
• Source: Istanbul University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Pulmonary Hypertension (PH) is a hemodynamic and physiopathological condition that is defined as an increase in mean pulmonary artery pressure ≥25 mmHg when measured at rest. PH often progresses to heart failure and premature deaths. PH is a progressive disease that has many causes, which can affect people of all ages, is characterized by shortness of breath, reduced exercise tolerance, psychological distress and tiredness and reduced quality of life. Surveys of SF-36, 'Nottingham Health Profiles' and 'Minnesota Life with Heart Failure' surveys are routinely performed in PH clinically. However, none of the questionnaires are specific to pulmonary hypertension, so they are incomplete in determining the condition of the disease and the patients. There is no Turkish questionnaire for patients with pulmonary hypertension and other surveys used are inadequate in determining the condition of the patient and the patient since they are not specific to the disease. The aim is to provide a Turkish questionnaire that is specific to pulmonary hypertension in the literature.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 101
• Est. completion date: September 2017
• Est. primary completion date: August 2017
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Have been diagnosed with Pulmonary Hypertension

• Following at least 6 months of Pulmonary Hypertension policlinic

• Native Turkish

• People age 18 years or older

Exclusion Criteria:

• Those with cognitive impairment

• Those who have difficulty understanding or speaking Turkish

Related Conditions & MeSH terms

• Hypertension
• Hypertension, Pulmonary
• Pulmonary Hypertension

Intervention

Other:
• Quality of Life
Patients self administor quality of life questionnaires such as Minnesota Living with Heart Failure Questionnaire and EmPHasis-10 questionnaire

Locations

Country	Name	City	State
Turkey	Istanbul University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Validity	Validity of EmPHasis-10 Questionnaire	8 months
Primary	Reliability	Reliability of EmPHasis-10 Questionnaire	8 months